CME

CME Group
D

CME

Arincen73/100B

CME Group revenue 2000–2026

CME Group's revenue in Q3 FY2026, the three months to 30 September 2026, was 1.74B USD, up 13.0% on the same quarter a year before. CME Group's revenue over the last twelve months was 6.97B USD, up 9.0% on the twelve months before. In fiscal year 2025 it was 6.52B USD, up 6.4% on the year before.

Last updated 8 Nov 2026 · Next report 3 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 20266.97B+8.99%5.88B4.40B
FY202531 Dec 20256.52B+6.37%5.61B4.04B
FY202431 Dec 20246.13B+9.88%5.28B3.53B
FY202331 Dec 20235.58B+11.15%4.75B3.23B
FY202231 Dec 20225.02B+7.03%4.27B2.69B
FY202131 Dec 20214.69B-3.97%3.85B2.64B
FY202031 Dec 20204.88B+0.32%4.03B2.11B
FY201931 Dec 20194.87B+12.96%3.97B2.12B
FY201831 Dec 20184.31B+18.24%3.64B1.96B
FY201731 Dec 20173.64B+1.38%3.08B4.06B
FY201631 Dec 20163.60B+8.07%3.05B1.53B
FY201531 Dec 20153.33B+6.89%2.75B1.25B
FY201431 Dec 20143.11B+6.00%2.53B1.13B
FY201331 Dec 20132.94B+0.74%2.38B976.80M
FY201231 Dec 20122.91B-11.16%2.38B896.30M
FY201131 Dec 20113.28B+9.22%2.76B1.81B
FY201031 Dec 20103.00B+14.96%2.53B951.40M
FY200931 Dec 20092.61B+2.02%2.08B825.80M
FY200831 Dec 20082.56B+45.83%2.06B715.49M
FY200731 Dec 20071.76B+61.12%1.40B658.53M
FY200631 Dec 20061.09B+22.50%789.89M407.35M
FY200531 Dec 2005889.77M+23.31%625.39M306.86M
FY200431 Dec 2004721.55M+34.61%483.49M219.56M
FY200331 Dec 2003536.04M+14.28%489.46M122.13M
FY200231 Dec 2002469.08M+18.27%429.22M94.07M
FY200131 Dec 2001396.63M+75.07%361.56M68.30M
FY200031 Dec 2000226.55M—0.00-5.91M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

CME Group revenue growth by segment

Q3 FY2026 against Q3 FY2025

clearing and transaction fees1.38B
+12.2%
MarketData243.10M
+20.0%
OtherRevenue116.10M
+8.3%

CME Group revenue by segment over time

clearing and transaction fees MarketData OtherRevenue
Fiscal yearclearing and transaction feesMarketDataOtherRevenue
FY20255.28B +5.9%803.10M +13.1%436.40M +1.1%
FY20244.99B +8.7%710.20M +7.0%431.70M +32.1%
FY20234.59B +10.8%663.70M +8.6%326.70M +22.9%
FY20224.14B +10.0%610.90M +5.9%265.80M -23.6%
FY20213.77B -3.4%576.90M +5.8%347.70M -21.1%
FY20203.90B -1.2%545.40M +5.2%440.80M +9.3%
FY20193.95B +7.6%518.50M +15.3%403.40M +109.2%
FY20183.67B 449.60M 192.80M

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about CME Group's revenue

Source: Financial Modeling Prep